fda compounding glp-1 enforcement news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA's compounded GLP-1 limits will
Description
PCOD (Polycystic Ovarian Disease) and PCOS (Polycystic Ovary Syndrome) are among the most common hormonal disorders affecting women today.
Lose weight safely with prescription weight-loss injections at NuBody Concepts

Supports metabolic balance alongside diet and activity

Abrupt cessation of GLP-1 receptor agonists can result in regaining lost weight rapidly
Learn how PURIS Pea Protein can make your products more attractive to GLP-1 users.

Always consult with your healthcare provider regarding your medication management
